$85.2 Million is the total value of Ally Bridge Group (NY) LLC's 19 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 77.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BDTX | Sell | BLACK DIAMOND THERAPEUTICS I | $1,820,128 | -54.9% | 634,191 | -20.7% | 2.14% | -56.3% |
| PRAX | Sell | PRAXIS PRECISION MEDICINES I | $1,806,393 | -50.9% | 1,056,370 | -67.0% | 2.12% | -52.4% |
| Exit | RAPID MICRO BIOSYSTEMS INC-A | $0 | – | -403,284 | -100.0% | -0.49% | – | |
| Exit | MDXHEALTH SA-ADRsponsored ads | $0 | – | -349,552 | -100.0% | -1.44% | – | |
| MDVL | Exit | MEDAVAIL HOLDINGS INC | $0 | – | -5,894,897 | -100.0% | -1.75% | – |
| Exit | MARINUS PHARMACEUTICALS INC | $0 | – | -390,418 | -100.0% | -5.14% | – | |
| VRDN | Exit | VIRIDIAN THERAPEUTICS INC | $0 | – | -201,752 | -100.0% | -5.81% | – |
| VRNA | Exit | VERONA PHARMA PLC - ADRsponsored ads | $0 | – | -487,631 | -100.0% | -12.49% | – |
| RETA | Exit | REATA PHARMACEUTICALS INC-Acl a | $0 | – | -105,558 | -100.0% | -13.04% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Fan Yu #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MEDAVAIL HOLDINGS INC | 11 | Q2 2023 | 8.9% |
| UNUM THERAPEUTICS INC | 8 | Q3 2022 | 7.3% |
| RAPID MICRO BIOSYSTEMS INC-A | 8 | Q2 2023 | 3.5% |
| FATE THERAPEUTICS INC | 7 | Q2 2022 | 5.8% |
| VIRIDIAN THERAPEUTICS INC | 7 | Q2 2023 | 6.8% |
| SYROS PHARMACEUTICALS INC | 7 | Q2 2022 | 4.9% |
| REPLIGEN CORP | 7 | Q4 2022 | 6.5% |
| NAUTILUS BIOTECHNOLOGY INC | 7 | Q4 2022 | 3.8% |
| ARVINAS INC | 6 | Q1 2022 | 7.5% |
| NUVATION BIO INC | 6 | Q2 2022 | 4.9% |
View Ally Bridge Group (NY) LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cogent Biosciences, Inc. | November 19, 2020 | 1,420,500 | 8.0% |
View Ally Bridge Group (NY) LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-06-21 |
| 13F-HR | 2023-05-15 |
| 4 | 2023-03-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Ally Bridge Group (NY) LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.